AIM
VIVS

ARK Investment Management’s VivoSim Labs VIVS Stock Holding History

ARK Investment Management’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,859
Closed -$302K – 230
2022
Q4 		$302K Sell
17,859
-5,047
-22% -$101K ﹤0.01% 208
2022
Q3 		$563K Sell
22,906
-1,397
-6% -$44.6K ﹤0.01% 212
2022
Q2 		$703K Sell
24,303
-1,206
-5% -$37.5K ﹤0.01% 234
2022
Q1 		$1.15M Sell
25,509
-2,004
-7% -$83.4K ﹤0.01% 235
2021
Q4 		$1.2M Sell
27,513
-4,286
-13% -$276K ﹤0.01% 253
2021
Q3 		$2.6M Sell
31,799
-3,854
-11% -$352K 0.01% 245
2021
Q2 		$4.02M Sell
35,653
-14,865
-29% -$1.49M 0.01% 253
2021
Q1 		$5.84M Sell
50,518
-66,534
-57% -$10.4M 0.01% 201
2020
Q4 		$17.3M Sell
117,052
-1,481
-1% -$169K 0.05% 143
2020
Q3 		$11.3M Buy
118,533
+5,456
+5% +$703K 0.07% 106
2020
Q2 		$14.9M Buy
113,077
+17,607
+18% +$2.15M 0.16% 71
2020
Q1 		$9.39M Buy
95,470
+14,222
+18% +$1.15M 0.23% 58
2019
Q4 		$6.94M Buy
81,248
+2,294
+3% +$215K 0.17% 67
2019
Q3 		$4.94M Sell
78,954
-9,099
-10% -$766K 0.11% 75
2019
Q2 		$11.1M Buy
88,053
+4,725
+6% +$893K 0.28% 50
2019
Q1 		$19.8M Buy
83,328
+8,079
+11% +$2.03M 0.57% 36
2018
Q4 		$17.3M Buy
75,249
+453
+0.6% +$114K 0.7% 31
2018
Q3 		$20.6M Buy
74,796
+12,878
+21% +$3.87M 0.62% 40
2018
Q2 		$20.8M Buy
61,918
+15,061
+32% +$4.96M 0.76% 38
2018
Q1 		$11.6M Buy
46,857
+22,309
+91% +$6.51M 0.58% 48
2017
Q4 		$7.89M Buy
24,548
+13,603
+124% +$5.06M 0.63% 49
2017
Q3 		$5.83M Buy
10,945
+4,924
+82% +$2.62M 0.71% 48
2017
Q2 		$3.8M Buy
6,021
+3,453
+134% +$2.32M 0.74% 42
2017
Q1 		$1.96M Buy
2,568
+667
+35% +$528K 0.57% 42
2016
Q4 		$1.55M Buy
+1,901
New +$1.51M 0.56% 39

Other funds holding VIVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

ARK Investment Management's VIVS Position: Q1 2023 in Review

ARK Investment Management sold out of VivoSim Labs (VIVS) in Q1 2023, closing a stake of 17,859 shares — an estimated $302K sold.

ARK Investment Management first reported a position in VIVS in Q4 2016 and held it in 25 quarters. The position peaked at $20.8M in Q2 2018. 35 funds tracked by Wall St. Rank hold VIVS as of Q1 2023.

  • ARK Investment Management reported no remaining VivoSim Labs position as of Q1 2023 after selling out during the quarter.
  • ARK Investment Management sold 17,859 VivoSim Labs shares in Q1 2023, an estimated $302K.
  • ARK Investment Management first reported a position in VivoSim Labs in Q4 2016 and held it in 25 quarters.
  • ARK Investment Management's VivoSim Labs position peaked at $20.8M in Q2 2018.
  • 35 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2023.

Based on ARK Investment Management's 13F filing for Q1 2023, filed 17 Apr 2023.